Literature DB >> 4163645

Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis.

M F Kahn, M Bedoiseau, S de Sèze.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163645      PMCID: PMC1901593     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  15 in total

1.  THIOGUANINE IN THE TREATMENT OF CERTAIN AUTOIMMUNE, IMMUNOLOGIC AND RELATED DISEASES.

Authors:  D J DEMIS; C S BROWN; W H CROSBY
Journal:  Am J Med       Date:  1964-08       Impact factor: 4.965

2.  INHIBITION BY 6-MERCAPTOPURINE OF POLYARTHRITIS INDUCED BY FREUND'S ADJUVANT.

Authors:  J L KALLIOMAEKI; H A SAARIMAA; P TOIVANEN
Journal:  Ann Rheum Dis       Date:  1964-01       Impact factor: 19.103

3.  STUDIES ON ADJUVANT-INDUCED POLYARTHRITIS IN RATS. 3. THE EFFECT OF "IMMUNOSUPPRESSIVE AGENTS" ON ARTHRITIS AND TUBERCULIN HYPERSENSITIVITY.

Authors:  J R WARD; R S CLOUD; E L KRAWITT; R S JONES
Journal:  Arthritis Rheum       Date:  1964-12

4.  STEROID THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS BASED ON IMMUNOLOGIC CONSIDERATIONS.

Authors:  K LANGE; R ORES; W STRAUSS; M WACHSTEIN
Journal:  Arthritis Rheum       Date:  1965-04

5.  Chemical suppression of the immune response.

Authors:  G H HITCHINGS; G B ELION
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

6.  [Favorable course of a case of periarteritis nodosa occurring during rheumatoid arthritis and treated with penicillamine and chlorambucil. Presentation of patient].

Authors:  S de Sèze; M F Kahn; N Debeyre; G Cayla; S Lisfranc
Journal:  Rev Rhum Mal Osteoartic       Date:  1965-05

7.  Treatment of rheumatoid arthritis with immunosuppressive drugs. II. Immunological study.

Authors:  J Brocteur; C Moens
Journal:  Acta Rheumatol Scand       Date:  1965

8.  Treatment of collagen diseases with cytostatics.

Authors:  I Lorenzen; A Videbaek
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

9.  Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study.

Authors:  C Moens; J Brocteur
Journal:  Acta Rheumatol Scand       Date:  1965

10.  Production of graft-versus-host disease in the rat and its treatment with cytotoxic agents.

Authors:  G W Santos; A H Owens
Journal:  Nature       Date:  1966-04-09       Impact factor: 49.962

View more
  9 in total

1.  Vasculitis associated with rheumatoid arthritis: a case-control study.

Authors:  Ashima Makol; Cynthia S Crowson; David A Wetter; Olayemi Sokumbi; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-01-17       Impact factor: 7.580

2.  Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis.

Authors:  E J Denman; A M Denman; B M Greenwood; D Gall; R B Heath
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

Review 3.  Current therapy of rheumatoid arthritis.

Authors:  E J Kamin; C V Multz
Journal:  Calif Med       Date:  1969-01

4.  Rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

5.  Suppressant effect of procarbazine and its comparison with anti-lymphocyte serum in adjuvant-induced polyarthritis in rats.

Authors:  G J Possanza; P B Stewart
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

Review 6.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 7.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

8.  Azathioprine in rheumatoid arthritis.

Authors:  M Mason; H L Currey; C G Barnes; J F Dunne; B L Hazleman; I D Strickland
Journal:  Br Med J       Date:  1969-02-15

Review 9.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.